Fundz
Real-time · AI · Cross-signal

Genomenon, Inc. just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Genomenon, Inc., plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
Watch the 2-minute tour · with sound

Genomenon Partners with Genomize to Integrate Mastermind and CKB into Platform

Mar 27, 2025about 1 year ago

Contract Type

partnership

Ann ArborBiotechnologyHardwareresearch

Description

Genomize and Genomenon have announced a strategic partnership to integrate both Mastermind and CKB into the Genomize platform. This collaboration aims to provide more comprehensive and accurate genomic insights, ultimately improving patient outcomes and advancing precision medicine. The partnership will expand access to curated genomic data and facilitate more informed decision-making in research and clinical settings.

Company Information

Company

Genomenon, Inc.

Location

3135 S. STATE STREET

Ann Arbor, Michigan, United States

About

Genomenon is a genomics intelligence company dedicated to improving the quality of life of genetic disease and cancer patients by making genomic information actionable. Blending the power of AI with the precision of genomic expertise, the company empowers pharmaceutical companies and the clinical diagnostic community with empirical genomic evidence and insights that both support the development of novel therapeutics and speed diagnostic assessments and treatment recommendations.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Genomenon, Inc.'s next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months